CHRISTIE KUSMIEREK: Open Payments
NPI 1811236110 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$332 in 15 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $39 · 2025 $332
Food & beverage: $332
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $58 |
| AstraZeneca Pharmaceuticals LP | 2 | $42 |
| Alexion Pharmaceuticals, Inc. | 2 | $37 |
| Legend Biotech USA Inc. | 1 | $28 |
| Agios Pharmaceuticals, Inc. | 1 | $28 |
| Regeneron Healthcare Solutions, Inc. | 1 | $28 |
| Celgene Corporation | 1 | $23 |
| Teleflex LLC | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| Geron Corporation | 1 | $17 |
Products named: CARVYKTI, ULTOMIRIS, PYRUKYND, LYNOZYFIC, IMFINZI, OPDUALAG, ARROW, RYBREVANT.
Industry payments across NY — which companies pay providers there.
